Abstract:Most of the conventional in vitro models to test biomaterial-driven vascularization are too simplistic to recapitulate the complex interactions taking place in the actual cell microenvironment, which results in a poor prediction of the in vivo performance of the material. However, during the last decade, cell culture models based on microfluidic technology have allowed attaining unprecedented levels of tissue biomimicry. In this work, we propose a microfluidic-based 3D model to evaluate the effect of bioactive biomaterials capable of releasing signaling cues (such as ions or proteins) in the recruitment of endogenous endothelial progenitor cells, a key step in the vascularization process. The usability of the platform is demonstrated using experimentally-validated finite element models and migration and proliferation studies with rat endothelial progenitor cells (rEPCs) and bone marrow-derived rat mesenchymal stromal cells (BM-rMSCs). As a proof of concept of biomaterial evaluation, the response of rEPCs to an electrospun composite made of polylactic acid with calcium phosphates nanoparticles (PLA+CaP) was compared in a co-culture microenvironment with BM-rMSC to a regular PLA control. Our results show a significantly higher rEPCs migration and the upregulation of several pro-inflammatory and proangiogenic proteins in the case of the PLA+CaP. The effects of osteopontin (OPN) on the rEPCs migratory response were also studied using this platform, suggesting its important role in mediating their recruitment to a calcium-rich microenvironment. This new tool could be applied to screen the capacity of a variety of bioactive scaffolds to induce vascularization and accelerate the preclinical testing of biomaterials. STATEMENT OF SIGNIFICANCE: For many years researchers have used neovascularization models to evaluate bioactive biomaterials both in vitro, with low predictive results due to their poor biomimicry and minimal control over cell cues such as spatiotemporal biomolecule signaling, and in vivo models, presenting drawbacks such as being highly costly, time-consuming, poor human extrapolation, and ethically controversial. We describe a compact microphysiological platform designed for the evaluation of proangiogenesis in biomaterials through the quantification of the level of sprouting in a mimicked endothelium able to react to gradients of biomaterial-released signals in a fibrin-based extracellular matrix. This model is a useful tool to perform preclinical trustworthy studies in tissue regeneration and to better understand the different elements involved in the complex process of vascularization.

Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform

Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic

Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation

Microfluidic design of tumor vasculature and nanoparticle uptake by cancer cells

A Microfluidic Platform for Multi-Size 3D Tumor Culture, Monitoring and Drug Resistance Testing

A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D Microenvironments

Remote-Loaded Platelet Vesicles for Disease-Targeted Delivery of Therapeutics

Blood-Vessel-on-a-Chip Platforms for Evaluating Nanoparticle Drug Delivery Systems

Nanoscale Platforms for Messenger RNA Delivery

Discovery of a Peptoid-Based Nanoparticle Platform for Therapeutic mRNA Delivery via Diverse Library Clustering and Structural Parametrization

Evaluation of a targeted drug delivery system on breast tumor spheroids on a chip

Multimicrochannel Microneedle Microporation Platform for Enhanced Intracellular Drug Delivery

Droplet Microfluidics for Tumor Drug‐Related Studies and Programmable Artificial Cells

A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays

Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis

Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications

Microfluidics‐Prepared Ultra‐small Biomimetic Nanovesicles for Brain Tumor Targeting

An Integrated Microfluidic 3D Tumor System for Parallel and High-Throughput Chemotherapy Evaluation

Microfluidic 3D platform to evaluate endothelial progenitor cell recruitment by bioactive materials

In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery

Evaluating Nanoparticles Penetration by a New Microfluidic Hydrogel-Based Approach